One Person's 68-Day Experience with Omnipod 5: What Worked and What Didn't

A long-time insulin pen user tested the Omnipod 5 automated insulin pump system for over two months. Here's what they learned about the technology's strengths, limitations, and real-world challenges.

Video report, corroborated with 5 indexed studies

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cureresearchclinical trial

Key takeaways

Omnipod 5's automated algorithm can improve overnight blood sugar control, but it may not work the same way for everyone
Real-world device issues—like leaking pods, dropped signals, and infusion site problems—can frustrate users even when the technology works well on paper
The system's algorithm sometimes conflicts with how users prefer to manage their own blood sugars
When the system functioned smoothly, users reported impressive results; the experience was highly variable

Testing Omnipod 5: One User's Journey

After 28 years of managing Type 1 diabetes primarily with insulin pens, one long-term user decided to test the Omnipod 5 automated insulin pump system for 68 days. The goal was clear: see whether this technology—which automates insulin delivery using an algorithm—could improve their daily diabetes management. What followed was a mixed experience that revealed both the promise and the practical frustrations of automated pump therapy.

The Algorithm: Brilliant in Theory, Sometimes Frustrating in Practice

The Omnipod 5's core feature is its algorithm—the system's automated decision-maker that continuously monitors blood sugars and adjusts insulin delivery in the background without requiring user input. For this tester, the algorithm delivered one major win: it made sleeping through the night easier, as the system could adjust insulin levels automatically during sleep.

However, the same algorithm that impressed them also created friction. The system's approach to managing blood sugars sometimes clashed with how this user preferred to handle their own diabetes. Rather than a one-size-fits-all solution, the automated system highlighted an important reality: what works brilliantly for the algorithm may not match each person's individual management style.

When Technology Meets Real Life: Device Challenges

On paper, the Omnipod 5 appears nearly flawless. In daily use, however, this tester encountered multiple obstacles. Leaking pods, painful infusion sites, and dropped wireless signals interrupted the smooth operation they had hoped for. These practical issues meant that even when the algorithm functioned well, the overall experience could become frustrating.

By the end of the 68-day trial, removing the final pod felt like a relief. Despite respecting the technology's capabilities, this user chose to return to insulin pens—at least for now. Their experience underscores a key lesson: device reliability and user comfort matter as much as algorithmic sophistication.

When It Worked, It Worked Well

Despite the setbacks, this tester found moments when the Omnipod 5 truly impressed. When the system ran smoothly, blood sugar control improved noticeably, and the user discovered practical tips that helped bring their average blood sugars closer to target. These wins demonstrated that the technology has genuine potential—but only when hardware, algorithms, and individual user needs align.

The takeaway is nuanced: Omnipod 5 may be genuinely valuable for some users, particularly those whose management style aligns with the system's automated approach and who experience fewer hardware issues. For others, the frustrations may outweigh the benefits.

Evidence label

Origin: YouTube community video (Video report). Evidence: Video report, corroborated with 5 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.